Pricing Log in Create free account

AEON Biopharma, Inc. (AEON) vs Phio Pharmaceuticals Corp. (PHIO)

AEON Biopharma, Inc. and Phio Pharmaceuticals Corp. are both Biotechnology companies. AEON Biopharma, Inc. and Phio Pharmaceuticals Corp. are of similar size ($9.4M and $9.3M). Across the 7 metrics below, Phio Pharmaceuticals Corp. leads on 5 and AEON Biopharma, Inc. on 2.

Valuation

Metric AEON PHIO Biotechnology median
P/E n/m n/m 10.60
P/S n/m 68.34 9.40
P/B n/m 0.74 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.26 0.66
EV/Sales n/m (25.52) 9.02
Earnings yield (2,455.56%) (174.15%) (32.88%)
Free cash flow yield (150.03%) (131.34%) (23.13%)

Profitability

Metric AEON PHIO Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 350.00% (113.71%) (51.96%)
Return on assets (621.70%) (100.78%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AEON PHIO Biotechnology median
Revenue growth (TTM) — 78.95% 6.76%
EPS growth (last fiscal year) (105.42%) 84.03% 29.88%
Revenue growth, 5-year CAGR — (21.62%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AEON PHIO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.54 8.39 4.97
Net debt to EBITDA (2.48) 2.28 1.01

Dividend

Metric AEON PHIO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric AEON PHIO Biotechnology median
Market cap 9.35m 9.30m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack